Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Galapagos Nv (GLPG)

96.71 -1.28 (-1.31%)

04-20 16:00

Open:

96.6

Pre. Close:

97.99

High:

97.22

Low:

96.53

Volume:

105,824

Market Cap:

4999M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

97.275 - 97.772

97.772 - 98.153

Low:

95.355 - 95.885

95.885 - 96.292

Close:

95.878 - 96.76

96.76 - 97.435

Technical analysis  (as of: 2018-04-20 4:30:10 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 117.15     One year: 122.41

Support:

Support1: 93.01    Support2: 77.38

Resistance:

Resistance1: 100.30    Resistance2: 104.80

Pivot:

97.02

Moving Averages:

MA(5): 96.90     MA(20): 97.76

MA(100): 101.72     MA(250): 93.86

MACD:

MACD(12,26): -1.58     Signal(12,26,9): -1.93

%K %D:

%K(14,3): 44.74     %D(3): 42.41

RSI:

RSI(14): 44.14

52-Week:

High: 121.09  Low: 72.9  Change(%): 13.5

Average Vol(K):

3-Month: 11682  10-Days 16954

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GLPG has closed above bottom band by 44.6%. Bollinger Bands are 56.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to GLPG's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-04-19T23:18:35-04:00
How Do Listed Companies Perform With A U.S. IPO?

2018-04-19T14:17:51-04:00
Investors mull Gilead's filgotinib in wake of Eli Lilly's/Incyte's baricitinib

2018-04-17T11:46:21-04:00
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position

2018-04-16T08:00:00-04:00
Your Daily Pharma Scoop: Intercept's OCA, MediciNova In NASH, Pulse Biosciences Data

2018-04-12T16:18:05-04:00
Galapagos on go with Phase 3 program for GLPG1690 in IPF

2018-04-11T08:30:00-04:00
Road To Financial Independence: My March 89-Stock Portfolio Review

2018-04-10T01:35:52-04:00
JF's Core Biotech Buys #10: Incyte Disappoints, Optimism Returns To Gene Therapy And A New Position

2018-04-03T13:10:52-04:00
JF's Core Biotech Buys #9: Shire In Play, Volatility Continues And Capitalizing On Weakness

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

51.23

Shares Float (M)

51.23

% Held by Insiders

% Held by Institutions

41.60

Shares Short (K)

224

Shares Short Prior Month (K)

343

Stock Financials

EPS

-2.660

EPS Est. Current Year

-2.760

EPS Est. Next Year

-3.550

EPS Est. Next Quarter

-1.080

Forward EPS

-4.259

Book Value (p.s.)

4.010

PEG Ratio

Profit Margin

Operating Margin

-57.60

Return on Assets (ttm)

-10.4

Return on Equity (ttm)

-13.8

Qtrly Rev. Growth

-42.7

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.671

Qtrly Earnings Growth

Operating Cash Flow (M)

-180.80

Levered Free Cash Flow (M)

14.98

atoplab.com

Valuation

P/E

-36.36

P/E Growth Ratio

-0.01

P/BV

24.12

P/S

1268695552.00

P/CF

-27.41

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.